Patterns and clinical manifestations of tuberculous myocarditis: a systematic review of cases

The Pan African Medical Journal
Brian Nyasani MichiraDuncan Mwangangi Matheka

Abstract

Tuberculosis is a rare cause of myocarditis. It is however associated with a high mortality when it occurs and is often diagnosed at post-mortem. Tuberculous myocarditis prevalence in males is twice that in females. Most of the reported cases of tuberculous myocarditis are predominantly in immunocompetent patients. Out of the reported fatalities (sudden cardiac deaths), eighty one percent (81%) occur in the 'young' patients (below 45years). Antituberculosis drug therapy does not appear to offer mortality benefit against sudden cardiac deaths.

Citations

Dec 3, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D Leoni, J Rello
Sep 29, 2019·Heart·Lucia Agoston-ColdeaDalma Horvat
Jul 28, 2019·Clinical Medicine : Journal of the Royal College of Physicians of London·Shilpa ManupatiDavid Shelton
Oct 28, 2019·Indian Journal of Pediatrics·Pawan KumarRakesh Panwar
Jun 11, 2016·Experimental and Therapeutic Medicine·Manyi RenJingquan Zhong
Mar 19, 2021·Journal of the American Heart Association·José Patricio López-LópezUNKNOWN Neglected Tropical Diseases, Other Infectious Diseases Affecting the Heart (the NET‐Heart Project)
Mar 18, 2021·Curēus·Nikhil ChoudharyRanajit B Naik

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

Gruźlica i choroby płuc; tuberculosis et pneumonologia
K Kopaczyńska
Problemy tuberkuleza
A K Poleshchuk
North Carolina Medical Journal
B F FETTER
© 2021 Meta ULC. All rights reserved